Clinical Trial Update: A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II study of HMPL-504 in lung sarcomatoid carcinoma and other non-small cell lung cancers is ongoing with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Sarcomatoid Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• HMPL-504 (HMPL-504)

Snippet

Sponsor: Hutchison Medipharma Limited | Conditions: Lung Sarcomatoid Carcinoma | Phase 2 | Status: UNKNOWN